AzaSite® gives you 24 hours of confident coverage in every drop

Broad-spectrum coverage against the most common gram-positive and gram-negative bacteria as well as
atypical bacteria.
Therapeutic concentrations in rabbit eyelid and conjunctiva with 1 drop per 24-hour period. (1)
Gel-forming drop persists on the ocular surface much longer than conventional aqueous drops, (2,3) with minimal blurring.
The easiest dosing regimen among all ocular anti-infectives. (4,5,6)

Home | Inspire Pharmaceuticals | Privacy Policy | Terms & Conditions | Contact Us

Please see full Prescribing Information for AzaSite®.

AzaSite® (azithromycin ophthalmic solution) 1% is indicated for the treatment of bacterial conjunctivitis caused by the following organisms: CDC coryneform group G,* Staphylococcus aureus, Streptococcus mitis group, Streptococcus pneumoniae, and Haemophilus influenzae.

The recommended dosing regimen for AzaSite® is 1 drop twice a day for 2 days, followed by 1 drop once a day for the next 5 days, for a total of 9 drops per affected eye.

Important Safety Information: AzaSite® should not be injected subconjunctivally or introduced directly into the anterior chamber of the eye or otherwise administered systemically. In clinical trials, the most common ocular adverse event was eye irritation, which occurred in 1% to 2% of patients.

*Efficacy for this organism was studied in fewer than 10 infections.

This web site is intended only for healthcare providers in the United States.